15289-s-bos

114 | Chapter 7 • Currently the only available Lp(a) lowering agents are estrogens, niacin, mipomersen, and lomitapide with either no effect on CVD outcome (estrogens, and niacin), or an unknown effect on CVD outcome (mipomersen, and lomitapide). • New drugs (ISIS apo(a) Rx) are being developed that will bemore commonly available and more specific for Lp(a) lowering. Acknowledgements We want to thank M T Mulder (PhD) for her help contributing to the writing, and for creating the figures.We alsowant to thankWBramer for his help searching the literature. Conflict of interest There are no conflicts of interest